Sulfonamide (medicine)

Sulfonamides, or sulfa drugs, are a class of antibacterial medications typically used to treat certain types of bacterial infections. Developed in the 1930s, sulfa drugs were among the first "miracle drugs" that could save patients with potentially fatal bacterial infections such as pneumonia. Although penicillin and other more powerful drugs replaced sulfa drugs over time, they played a critical role in the development of antibiotics. Sulfa drugs still are used in certain circumstances. Sulfa drugs are used in the treatment of urinary tract infections and other types of infections, although their use has declined in some regions due to antimicrobial resistance. They also can be used to control seizures and treat other medical problems. Like most medicines, sulfa drugs have a range of side effects, some of which include headache, dizziness, diarrhea, and nausea. Sulfa drugs also can trigger allergic reactions in some patients that can result in rash, hives, difficulty breathing, or swelling.

Brief History

Prior to the 1930s, there were very limited effective medical treatments for bacterial infections, and most therapies were unreliable or only partially effective. As a result, such infections could spread with ease. Worse, with no reliable means of helping patients recover, bacterial diseases such as pneumonia and tuberculosis often were fatal. Clearly, a solution to this problem was needed.

The eventual breakthrough in the treatment of bacterial infections came through the work of German physician and researcher Gerhard Domagk. In the early 1930s, Domagk was employed by I.G. Farbenindustrie, a German industrial conglomerate. At the time, he was working on a project that had him tasked with testing various industrial chemicals for possible medical uses. One of the chemicals Domagk tested was a special group of dyes called azo dyes. These dyes could change the color of fabrics by binding some of the proteins found in those fabrics. Domagk supposed that the chemical compounds in azo dyes also might be able to bind bacterial proteins and thus inhibit their action. One such compound, which Domagk and his team called prontosil rubrum, proved to do just that when it was administered to laboratory mice carrying the bacterial infection Streptococcus. When Domagk subsequently patented the compound as Prontosil and published a report on the substance in 1935, the world's first sulfa drug was officially created.

Shortly after Prontosil's debut, scientists studying the compound noticed that its molecules split in two when ingested, leaving the active part of the substance—sulfanilamide—separate from the inactive part. Because the sulfanilamide part of the Prontosil molecule was not covered by Domagk's patent, it could be used to make similar medicinal substances. That cleared the way for the production of a whole range of sulfa drugs, including sulfapyridine, sulfathiazole, and sulfadiazine. With the introduction of these drugs, doctors finally had an effective way to treat pneumonia, Staphylococcal (staph) infections, and other life-threatening bacterial infections.

Although their discovery was a major medical breakthrough, sulfa drugs were used as first-line treatment for bacterial infections for only a short time. In part, this was because they had some serious side effects that often made them difficult to take. More significantly, the eventual development of penicillin and other more effective antibiotics ultimately made sulfa drugs obsolete in most cases.

Overview

Sulfa drugs are a type of medication that prevents the growth of bacteria in the body. Different types of sulfa drugs can be taken orally, topically, or through other routes of administration. Most often, sulfa drugs are prescribed for the treatment of some infections, particularly urinary tract infections, certain types of gastrointestinal infections, and opportunistic infections in patients who are immunocompromised. Sulfa drugs also are commonly used to treat certain types of eye and ear infections. Some orally administered sulfa drugs can be used to treat inflammatory bowel disease. Topical sulfa drugs can be used to treat burns, vaginitis, and eye infections. One commonly prescribed sulfa antibiotic is trimethoprim-sulfamethoxazole (TMP-SMX), used to treat urinary tract infections, skin infections, travelers’ diarrhea, Salmonella, and to prevent or treat Pneumocystis jirovecii (formerly Pneumocystis carinii) pneumonia in individuals undergoing chemotherapy. TMP-SMX is also recommended as a first-line treatment and preventive therapy for Pneumocystis jirovecii pneumonia in immunocompromised individuals.

One of the major drawbacks of sulfa drugs is their propensity to produce unpleasant and sometimes dangerous side effects. Some of the most common side effects include skin rashes, itching, dizziness, headaches, fatigue, diarrhea, nausea, vomiting, joint pain, and pallor. Patients taking sulfa drugs also may experience increased sensitivity to light. In rare cases, sulfa drugs can have more serious side effects. For example, patients taking sulfa drugs can develop hepatitis, certain types of anemias, and other blood disorders. Overuse of sulfa drugs can result in kidney damage. Some studies indicate that women who take sulfa drugs while pregnant, particularly in the first trimester and near delivery, have a greater chance of having a child with congenital abnormalities like neural tube defects and kernicterus.

Another concern related to sulfa drugs is their potential to cause allergic reactions. Many people are naturally allergic to sulfa and may experience a pronounced reaction in response to exposure to sulfa drugs. The most common signs of an allergic reaction to sulfa include the appearance of hives; swelling of the face, mouth, tongue, and throat; and a sudden drop in blood pressure. In more severe cases, exposure to sulfa can result in anaphylaxis, a severe allergic reaction that requires immediate medical attention. In rare cases, some patients who begin taking sulfa drugs may develop symptoms of serum sickness, which is a type of reaction specifically tied to the immune system's response to certain medicines used to treat immune conditions or to other substances administered to patients to protect them from germs or poisons. Symptoms of this type of reaction may include skin eruptions, hives, fever, drug-induced arthritis, or swollen lymph nodes. A person who is allergic to one particular sulfa drug may not be allergic to all sulfa drugs. Some people with sulfa allergies can take certain sulfa drugs without having a reaction, but this varies and should be evaluated by a healthcare professional. Sulfa drugs can also interact with other medications, leading to increased potassium levels or an increase in the effects of anticoagulants like warfarin.

Although more effective antibiotics have largely replaced them, sulfa drugs remain in clinical use. Because they are more affordable than their preferred antibiotic counterparts, sulfa drugs are used in developing countries where financial restrictions limit the availability of other medications. However, the rise of antimicrobial resistance limits their effectiveness in some regions. Clinical guidelines emphasize more selective use of sulfonamides due to increasing antimicrobial resistance.

Bibliography

“Gerhard Domagk.” Science History Institute, www.sciencehistory.org/education/scientific-biographies/gerhard-domagk/. Accessed 26 Mar. 2026.

“Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV.” Clinical Info HIV, 25 Feb. 2026, clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-opportunistic-infection. Accessed 26 Mar. 2026.

Kinman, Tricia. “Sulfa Allergies vs. Sulfite Allergies.” HealthLine, 26 May 2023, www.healthline.com/health/allergies/sulfa-sulfite. Accessed 26 Mar. 2026.

Lesch, John E. The First Miracle Drugs: How the Sulfa Drugs Transformed Medicine. Oxford UP, 2007.

Marks, Julie Lynn. “What are Sulfonamides? Uses, Warnings, Side Effects, and More.” Everyday Health, 29 Nov. 2022, www.everydayhealth.com/sulfonamides/. Accessed 26 Mar. 2026.

Ovung, Aben, and Jhimli Bhattacharyya. “Sulfonamide Drugs: Structure, Antibacterial Property, Toxicity, and Biophysical Interactions.” Biophysical Reviews, vol. 13, no. 2, 29 Mar. 2021, pp. 259–72, doi:10.1007/s12551-021-00795-9. Accessed 26 Mar. 2026.

“Sulfa Allergy. Which Medicine Should I Avoid?” Mayo Clinic, 25 Dec. 2025, www.mayoclinic.org/diseases-conditions/drug-allergy/expert-answers/sulfa-allergy/faq-20057970. Accessed 26 Mar. 2026.

“Sulfonamides.” Cleveland Clinic, 26 Feb. 2025, my.clevelandclinic.org/health/treatments/sulfonamides. Accessed 26 Mar. 2026.

Werth, Brian J. “Sulfonamides.” Merck Manual, May 2024, www.merckmanuals.com/professional/infectious-diseases/bacteria-and-antibacterial-drugs/sulfonamides. Accessed 26 Mar. 2026.